undamentalytics Newsletter
Sign in

Nexalin Technology, Inc. balance sheet

At the end of fiscal 2025, Nexalin Technology, Inc. had total assets of $4.6m, total liabilities of $887,333 and shareholders' equity of $3.7m. It held $654,783 in cash against $0 of debt.

Balance sheet

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents6621635805746551,005
Receivables1659138253
Inventory31154156175131233
Total current assets7537,4253,4303,9614,2991,862
Total assets7547,4323,6324,2234,6353,004
Accounts payable844658160156245239
Deferred revenue (current)130—————
Total current liabilities2,3641,9494255478871,485
Total debt5005000000
Total liabilities2,4361,9534255478871,485
Shareholders' equity−1,6825,4793,2073,6763,7481,519
Shares outstanding5m—7m—19m22m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: NXL vs QTEXNXL vs PAVMNXL vs POAS

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Nexalin Technology, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Nexalin Technology, Inc.